IMU Biosciences
London, United Kingdom
The foundation of IMU is built on the belief that deep systems level immunophenotyping at a population level, powered by the latest advancements in AI and Machine Learning, will lead to a totally new understanding of the immune system and help develop the next-generation precision medicines. IMU is fulfilling this vision with its proprietary discovery engine, and building a comprehensive Immune Atlas that covers the spectrum of health and disease, to advance precision medicine. Applying AI-driven data analytics to immunology research crystalised further when COVID-19 emerged, and the team leveraged its technology to understand the human immune response to the virus. IMU Biosciences has further validated and fine-tuned its unique approach in partnership with leading pharmaceutical and biotech companies.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2019
- Website
- imubiosciences.com/
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of IMU Biosciences?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now